0000899243-22-018605.txt : 20220518
0000899243-22-018605.hdr.sgml : 20220518
20220518162239
ACCESSION NUMBER: 0000899243-22-018605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanna Bastiano
CENTRAL INDEX KEY: 0001829069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22939383
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001829069
Sanna Bastiano
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Cell & Genetic Therapies
Common Stock
2022-05-16
4
S
0
7
250.56
D
41787
D
Common Stock
2022-05-16
4
S
0
8
251.37
D
41779
D
Common Stock
2022-05-16
4
S
0
7
252.43
D
41772
D
Common Stock
2022-05-16
4
S
0
15
253.99
D
41757
D
Common Stock
2022-05-16
4
S
0
8
254.44
D
41749
D
Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87).
Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88).
Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07).
Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32).
Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-05-18